Edilmar A. Alvarado

Barcelona, CT 08025, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

A Metagenomics Approach to Frailty in Patients With Cirrhosis Undergoing a Multifactorial Intervention.

A Metagenomics Approach to Frailty in Patients With Cirrhosis Undergoing a Multifactorial Intervention.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: May 19, 2025

Early portopulmonary hypertension predicts mortality in patients with cirrhosis: Insights from the PORTO-DETECT cohort.

Early portopulmonary hypertension predicts mortality in patients with cirrhosis: Insights from the PORTO-DETECT cohort.

Journal: Journal of hepatology

Published: January 21, 2025

Rivaroxaban to prevent complications of portal hypertension in cirrhosis: The CIRROXABAN study.

Rivaroxaban to prevent complications of portal hypertension in cirrhosis: The CIRROXABAN study.

Journal: Journal of hepatology

Published: November 14, 2024

Biomarkers of Frailty in Patients with Advanced Chronic Liver Disease Undergoing a Multifactorial Intervention Consisting of Home Exercise, Branched-Chain Amino Acids, and Probiotics.

Biomarkers of Frailty in Patients with Advanced Chronic Liver Disease Undergoing a Multifactorial Intervention Consisting of Home Exercise, Branched-Chain Amino Acids, and Probiotics.

Journal: Biomolecules

Published: September 18, 2024

Home exercise, branched-chain amino acids, and probiotics improve frailty in cirrhosis: A randomized clinical trial.

Home exercise, branched-chain amino acids, and probiotics improve frailty in cirrhosis: A randomized clinical trial.

Journal: Hepatology communications

Published: December 19, 2023

Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD.

Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD.

Journal: Journal of hepatology

Published: December 07, 2023

Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome.

Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome.

Journal: Journal of hepatology

Published: October 30, 2023

Improving primary prophylaxis of variceal bleeding by adapting therapy to the clinical stage of cirrhosis. A competing-risk meta-analysis of individual participant data.

Improving primary prophylaxis of variceal bleeding by adapting therapy to the clinical stage of cirrhosis. A competing-risk meta-analysis of individual participant data.

Journal: Alimentary pharmacology & therapeutics

Published: March 03, 2023

Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome.

Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome.

Journal: Transplantation

Published: December 08, 2022

Alcohol-related liver disease phenotype impacts survival after an acute variceal bleeding episode.

Alcohol-related liver disease phenotype impacts survival after an acute variceal bleeding episode.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: November 28, 2022

A multistrain probiotic increases the serum glutamine/glutamate ratio in patients with cirrhosis: a metabolomic analysis.

A multistrain probiotic increases the serum glutamine/glutamate ratio in patients with cirrhosis: a metabolomic analysis.

Journal: Hepatology communications

Published: November 08, 2022

Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding.

Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding.

Journal: Gut

Published: January 14, 2022

Showing 1-12 of 27

Last Updated: 09/26/2026